Skip to main content

Advertisement

SpringerLink
Log in

Dopamine agonist induced compulsive eating behaviour in a Parkinson’s disease patient

  • Case Report
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Case description: a patient diagnosed with type 2 diabetes mellitus and Parkinson’s disease developed a compulsive eating disorder when treated with a dopamine agonist, pramipexole. The patient had no history of psychiatric illnesses and upon the discontinuation of pramipexole his abnormal behavioural symptoms were resolved. Conclusion: Physicians treating Parkinson’s disease patients with dopamine replacement therapy should inquire about the development of any compulsive behaviours. Although uncommon, many of these non-motor symptoms go undiagnosed and can have a detrimental impact on a patient’s quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Antonini A, Cilia R. Behavioural adverse effects of dopaminergic treatments in Parkinson’s disease: incidence, neurobiological basis, management and prevention. Drug Saf. 2009;32(6):475–88.

    Article  CAS  PubMed  Google Scholar 

  2. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2006;21(4):524–9.

    Article  PubMed  Google Scholar 

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association; 2000.

  4. Miwa H, Kondo T. Alteration of eating behaviors in patients with Parkinson’s disease: possibly overlooked? Neurocase. 2008;14(6):480–4.

    Article  PubMed  Google Scholar 

  5. Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson’s disease. Curr Opin Neurol. 2007;20(4):484–92.

    Article  PubMed  Google Scholar 

  6. Weintraub D. Dopamine and impulse control disorders in Parkinson’s disease. Ann Neurol. 2008;64(Suppl 2):S93–100.

    PubMed  Google Scholar 

  7. Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial. Clin Ther. 2004;26(9):1427–35.

    Article  PubMed  Google Scholar 

  8. Weintraub D, Potenza MN. Impulse control disorders in Parkinson’s disease. Curr Neurol Neurosci Rep. 2006;6(4):302–6.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Sughra Naz (Toronto, Ontario, Canada).

Conflict of Interest

None to declare.

Author information

Authors and Affiliations

  1. Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Toronto, ON, M5S-3E2, Canada

    Waqas Khan

  2. Rouge Valley Hospital, Parkinson Clinic of Eastern Toronto and Movement Disorders Center, Suite 404, 2863 Ellesmere Road, Toronto, ON, M1E-5E9, Canada

    Abdul Qayyum Rana

Authors
  1. Waqas Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdul Qayyum Rana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdul Qayyum Rana.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khan, W., Rana, A.Q. Dopamine agonist induced compulsive eating behaviour in a Parkinson’s disease patient. Pharm World Sci 32, 114–116 (2010). https://doi.org/10.1007/s11096-009-9358-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-009-9358-0

Keywords

Search

Navigation